Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Onconetix (ONCO) Short term Debt (2023 - 2025)

Historic Short term Debt for Onconetix (ONCO) over the last 3 years, with Q3 2025 value amounting to $988000.0.

  • Onconetix's Short term Debt rose 69274.02% to $988000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $988000.0, marking a year-over-year increase of 69274.02%. This contributed to the annual value of $2641.0 for FY2023, which is N/A changed from last year.
  • As of Q3 2025, Onconetix's Short term Debt stood at $988000.0, which was up 69274.02% from $124631.0 recorded in Q3 2024.
  • In the past 5 years, Onconetix's Short term Debt ranged from a high of $988000.0 in Q3 2025 and a low of $2641.0 during Q4 2023
  • Moreover, its 3-year median value for Short term Debt was $11433.5 (2023), whereas its average is $144687.6.
  • Over the last 5 years, Onconetix's Short term Debt had its largest YoY gain of 109138.71% in 2024, and its largest YoY loss of 8124.29% in 2024.
  • Onconetix's Short term Debt (Quarter) stood at $2641.0 in 2023, then soared by 4619.08% to $124631.0 in 2024, then skyrocketed by 692.74% to $988000.0 in 2025.
  • Its last three reported values are $988000.0 in Q3 2025, $124631.0 for Q3 2024, and $2641.0 during Q2 2024.